Pharmaceutical Companies Face a Myriad of Barriers in New Orleans Market, According to a Recent Market Overview Now Available from HealthLeaders-InterStudy
December 8, 2011—Nashville, Tenn. —HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that pharmaceutical companies face an unfavorable market place in New Orleans. There are a myriad of barriers to market access, according to the recently published
New Orleans Market Overview.
New Orleans continues to have a physician shortage which can limit the number of prescriptions written. The market’s academic medical center, Louisiana State University School of Medicine, has strong conflict-of-interest policies for its physicians who deal with the pharmaceutical industry which creates a higher barrier to entry with these physicians, according to the report.
“New Orleans has a large uninsured population of about 19 percent of the market,” said HealthLeaders-InterStudy Analyst Jenny Kerr. “This will continue to present challenges to pharmaceutical sales.”
On the bright side, a new step-therapy bill passed in the Louisiana 2011 legislative session will allow physicians to override step-therapy requirements in some cases, which could benefit pharma sales, according to the report.
In addition to providing detailed analysis of levers and barriers in the market, the
New Orleans Market Overview answers the following questions:
- What two new hospitals are currently under construction in the market?
- How are physician contract negotiations with new managed Medicaid companies going?
- What two insurers are offering new narrow network plans?
You can view an abstract of the report
here.
Why Pharmaceutical Sales Representatives Need Market Overviews
Market Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation’s most dynamic metro areas. Market Overviews are updated throughout the year based on market events, allowing sales reps to be more nimble in their sales efforts.